Non steroidal anti-inflammatory drugs and ulcer complications, a risk factor analysis for clinical decision making;NSAID og ulcuskomplikationer. En analyse af risikofaktorer

Ugeskrift for Laeger

Volumn 159, Issue 24, 1997, Pages 3787-3791

  Hansen, Jane Møller ^a   Hallas, Jesper ^b   Lauritsen, Jens M ^b   Bytzer, Peter ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

AGE; AGED; ALCOHOLISM; ARTICLE; CORTICOSTEROID THERAPY; DECISION MAKING; DIGESTIVE SYSTEM ULCER; DYSPEPSIA; FEMALE; HUMAN; MALE; RISK FACTOR; SEX; SMOKING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PHARMACOEPIDEMIOLOGY; STOMACH ULCER;

EID: 0030947715     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993; 105: 1078-88.
2. Sommerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: 4624.
3. Griffin M, Piper J, Daugherty J, Snowden M, Ray W. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-63.
4. Langman MJS. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology 1989; 96: 640-6.
5. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA et al. Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8.
6. Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Ulcuskomplikationer i Fyns Amt i perioden 1980-1990; ændringer i indlæggelsesfrekvensen efter frigivelsen af potent ulcusmedicin til håndkøb?. Ugeskr Læger 1991; 153: 1402-5.
7. Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: 489-92.
8. Kurata JH, Corboy ED. Current peptic ulcer time trends. An epidemiological profile. J Clin Gastroenterol 1988; 10: 259-68.
9. Hallas J, Hansen NCG. Out-patient utilization of anti-asthma drugs by young adults; a prescription database analysis. J Intern Med 1993, 234: 65-70.
10. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for defined daily doses. Oslo: WHO, 1991.
11. EGRET version 0.26.10. Washington: Statistics and Epidemiology Research Corporation, 1990.
12. Sommerville K, Faulkner G, Langman M. Risk factors for non-steroidal anti-inflammatory drug-associated upper gastrointestinal bleeding. Eur J Gastroenterol Hepatol 1992; 4: 645-9.
13. Laporte J, Carné X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991; 337: 85-9.
14. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987; 147: 85-8.
15. Rodriguez LAG, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72.
16. Hallas J, Lauritsen J, Villadsen HD, Gram LF. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol 1995; 30: 43844.
17. Beardon P, Brown S, McDevitt D. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a case control study using record linkage in Tayside. Q J Med 1989; 71: 497-505.
18. Gabriel S, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 115: 787-96.
19. Bollini P, Rodriguez G, Gutthann S, Walker A. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med 1992; 152: 1289-95.
20. Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete M. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut 1991; 32: 7304.